Lead

A comprehensive analysis by the World Health Organization (WHO) and Gavi, the Vaccine Alliance, has found that nearly 20 million measles-related deaths have been averted in Africa since 2000, thanks to increasing vaccination coverage. The report, described as the first-ever detailed assessment of immunization targets on the continent, also shows that more than 500 million children were protected through routine immunization between 2000 and 2024.

Coverage Comparison

Three separate reports from AllAfrica, an aggregator of African news content, covered the analysis. All three emphasized the positive impact of consistent investment in immunization, with headlines highlighting the progress in measles vaccination. The framing was consistently optimistic, though one report adopted a more cautious tone, noting that "the progress is uneven, and even slowing." All sources quoted experts and used active language, with terms like "remarkable," "immense," and "life-saving" appearing in the coverage.

Key Claims

  • Nearly 20 million measles-related deaths averted since 2000, according to all three reports.
  • More than 500 million children protected through routine immunization between 2000 and 2024, as stated in all sources.
  • 44 African countries introduced a second dose of measles-containing vaccine into routine immunization, increasing coverage rates from 5% in 2000 to 55% in 2024.
  • Measles deaths halved in the African region, with a 40% drop in overall cases.
  • Nine countries reported consistently low measles incidence in 2023 and 2024, and Cabo Verde, Mauritius, and Seychelles achieved measles and rubella elimination status in 2025.
  • Routine immunization schedules now protect against 13 vaccine-preventable diseases, up from eight in 2000.
  • Meningitis deaths have fallen by 39%, and the malaria vaccine has been introduced in 25 countries.
  • At least 1.9 million lives were saved through vaccination in 2024 alone, with 42% attributed to measles vaccination.
  • 47 sub-Saharan African countries provide hepatitis B as part of routine vaccination, with 16 providing a birth dose.
  • 33 countries have introduced the rubella vaccine, and 29 offer the human papillomavirus vaccine.

Perspectives

While the analysis highlights remarkable achievements, experts caution that the continent remains off track towards the 90% immunization coverage target. Dr. Mohamed Janabi, WHO Regional Director, noted that "progress is uneven, and even slowing, leaving too many children unprotected." The reports identify rapid population growth, weak health systems, lack of integration of immunization into primary health care, and the impacts of climate change, humanitarian crises, and political instability as major hurdles. Continued investment and strong political commitment are deemed critical to sustain gains and protect future generations.

The analysis underscores the dual narrative of success and challenge: while measles deaths have plummeted and several countries have achieved elimination status, the overall immunization agenda faces significant obstacles. As the continent strives to meet the 2030 Immunization Agenda targets, the need for strengthened routine immunization and equitable access remains paramount.